Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

FIT-BioCeuticals Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (179)
Listed medicine compliance report (9)

Date

2022 (3)
2021 (18)
2020 (62)
2019 (36)
2018 (37)
2017 (32)

Search

Sponsor content

188 result(s) found, displaying 131 to 140

MenoPlus 8-PN Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Mushroom 6 Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Ubiquinol BioActive 150mg Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Paracea Forte Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
BabyBiotic 0+yrs Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Echinamide ImmunoBurst Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
ArthroPlex Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Liposomal R-ALA Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Overtraining Syndrome Support Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited
Caffeine + D-Ribose Energy Chews Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by FIT-BioCeuticals Limited

Pages

First page
Previous page
…
Page 10
Page 11
Page 12
Page 13
Current page 14
Page 15
Page 16
Page 17
Page 18
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia